Dr. Mary Pat Moyer is a biomedical scientist, entrepreneur, and passionate community activist for biotechnology business and education. Her company INCELL is an emerging biopharmaceutical company focused on areas where she is considered an expert: stem cells, regenerative medicine, cancer, and microbiology. She leads INCELL’s collaborations, contract services, and new product pipelines, including adult stem cell banking and applications; tumor cell testing; non-needle vaccines (e.g., HIV, influenza, biodefense); and more. She has pioneered technologies relevant to human stem cells and collaborative research programs with national and international scientists to seek new ways to prevent, treat and diagnose disease. She believes that new capabilities in personalized medicine are important to changing approaches in healthcare and to reducing costs.

Moyer is an elected fellow of the American Academy for Microbiology; consults for national and international government agencies such as the National Institutes of Health, World Health Organization, and the International Center for Infectious Disease, universities and industry; has numerous scientific publications including a book "Colon Cancer Cells"; is President of San Antonio Life Science Assn (SALSA); and co-founded several for-profit and non-profit entities. Her leadership, biomedical, and business recognition or awards include: E&Y Entrepreneur of the Year, international Athena Award, "Women of Voice and Vision”, "Healthcare Hero”, "Breaking the Glass Ceiling”, "Small Business Leadership”, Alamo Workforce Leadership Innovation award, and one of the "Top Ten Texas CEOs in Life Sciences”.

She is an advisor to science and technology education programs at DelMar College, St, Phillips Community College, Our Lady of the Lake University, University of Texas schools, the Texas A&M Biotechnology Program and other colleges and universities. She was on the UTHSCSA faculty for 20 years and is currently an adjunct UTHSCSA Professor of Surgery, Molecular Medicine and Microbiology, and adjunct Professor of Life Sciences at UTSA. She was the Texas Technology Initiative statewide Co-Chair for Biotechnology (which led the way to form the Emerging Technology Fund) and served on the State of Texas Workforce Investment Council 2006-2009. She is on many private company and public boards and was on the founding Boards for BioMedSA, SATAI/Startech, SALSA and others.

Moyer received her BS (1972) and MS (1974) degrees in Biology from Florida Atlantic University and a PhD (1981) in Microbiology from The University of Texas at Austin.